癌变·畸变·突变 ›› 1998, Vol. 10 ›› Issue (3): 144-148.doi: 10.3969/j.issn.1004-616x.1998.03.005

• 论著 • 上一篇    下一篇

药物诱导的小鼠肺肿瘤中雌、孕激素受体的研究

蒋义国 陈家􏲧  吴中亮 冯苏妹 林丽白   

  1. 广州医学院化学致癌研究所 广州 510182
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:1998-05-30 发布日期:1998-05-30

STUDY ON ESTROGEN AND PROGESTERONE RECEPTORS IN MOUSE LUNG TUMOR INDUCED BY URETHANE AND DIETHYLSTILBESTROL

Jiang Yiguo ,Chen Jiakun , Wu Zhongliang , Feng Sumei ,Ling Libai   

  1. Instit ute f or Chemical Carcinogenesis , Guangz hou Medical College , Guangz hou 510182
  • Received:1900-01-01 Revised:1900-01-01 Online:1998-05-30 Published:1998-05-30

摘要: 本文研究肺肿瘤组织中雌激素受体( ER) 和孕激素受体( PR) 的水平。小鼠注射乌拉坦和已烯雌酚诱导肺肿瘤,采用免疫组化方法测定肺肿瘤中的ER、PR。乌拉坦和已烯雌酚联合诱导的肺恶性肿瘤的ER、PR阳性率比单纯乌拉坦诱导的为高,说明已烯酚可能可提高癌组织性激素受体含量。ER 阳性率与恶性肿瘤大小有关,但与良性肿瘤大小无关;PR 阳性率与良、恶性肿瘤大小均无关。恶性肿瘤的ER、PR 阳性率(分别为4613 %和5215 %) 显著高于良性肿瘤(分别为1818 %和2012 %) 。良性肿瘤ER、PR 同时阳性率为1116 % ,同时阴性率为7215 %;恶性肿瘤ER、PR 同时阳性率为3113 % ,同时阴性率为3215 %。结果提示肺肿瘤可能为性激素依赖性肿瘤,并为肺癌的临床内分泌治疗提供依据。

关键词: 雌激素受体, 孕激素受体, 肺肿瘤

Abstract: To study the relationship between sex hormone receptors and lung tumor ,est rogen receptor ( ER) and progesterone receptor ( PR) were detected by immunohistochemical technique in mice lung tumors induced by urethane and diethylstilbest rol. The f requency of presence of ER and PR in malignant tumor were both higher than which were induced by urethane alone. Presence of ER correlated significantly with size of malignant tumors ,but not with size of benign tumors. PR did not correlate with size of both benign and malignant tumors. The ER and PR positive rates (46. 3 % and 52. 5 % respectively) of malignant tumors were significantly higher than those of benign tumors(18. 8 % and 20. 2 % respectively) . The positive rate for both ER and PR were 11.6 % in benign tumors and 31. 3 % in malignant tumors ,the negative rate were 72. 5 % and 32. 5 % respectively. The result suggested the est rogen dependency of lung tumor ,and also might be helpful for clinical endocrine therapy of lung cancer.

Key words: est rogen receptor, progesterone receptor, lung tumor